Announcements Trials
Browse Landscape

Phase

Phase 1/2 6Phase 1 5Phase NA 3Phase EARLY_PHASE1 1

Status

Unknown 3Completed 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5Thoracic 4Other solid neoplasm 2

Conditions

Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Pancreatic Neoplasms 1Liver Neoplasms 1Insulin-Like Growth Factor I, Resistance To 1

Interventions

Gemcitabine 218Fluorouracil 142Oxaliplatin 132Capecitabine 122pembrolizumab 113Irinotecan 110Leucovorin 104Bevacizumab 98Nivolumab 80Cisplatin 80130-nm albumin-bound paclitaxel 80Cetuximab 79Radiotherapy 78Albumin-Bound Paclitaxel 59Sorafenib 56Paclitaxel 53Cyclophosphamide 50Carboplatin 47Magnetic Resonance Spectroscopy 44Specimen Handling 39Docetaxel 37Taxes 36fludarabine 34Radiation 34durvalumab 33Ipilimumab 33Erlotinib Hydrochloride 33Biopsy 33Radiosurgery 27Folfox protocol 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Receptor Protein-Tyrosine Kinases × Gastrointestinal × Clear all
NCT00956436 2013-09-16

Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)

Biogen

Phase 1 Completed
40 enrolled
Gastrointestinal

Insulin-Like Growth Factor I, Resistance To, Carcinoma, Hepatocellular, Liver Neoplasms

NCT00632333 2011-07-21

Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer

Teikyo University

Phase 1 Unknown
9 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01266707 2010-12-24

Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma

Fukushima Medical University

Phase 1 Unknown
9 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01266720 2010-12-24

HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)

Fukushima Medical University

Phase 1 Unknown
6 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00561275 2008-07-15

Safety Study of Multiple Peptide Vaccine to Esophageal Cancer

Japanese Foundation for Cancer Research

Phase 1 Completed
6 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡